Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 52

1.

Water signal attenuation by D2O infusion as a novel contrast mechanism for 1H perfusion MRI.

Wang FN, Peng SL, Lu CT, Peng HH, Yeh TC.

NMR Biomed. 2013 Jun;26(6):692-8. doi: 10.1002/nbm.2914. Epub 2013 Jan 28.

PMID:
23355425
2.

The advantage of high relaxivity contrast agents in brain perfusion.

Cotton F, Hermier M.

Eur Radiol. 2006 Nov;16 Suppl 7:M16-26. Review.

PMID:
18655263
3.

The measurement of blood flow parameters with deuterium stable isotope MR imaging.

Furuya Y, Ikehira H, Obata T, Koga M, Yoshida K.

Ann Nucl Med. 1997 Nov;11(4):281-4.

PMID:
9460518
4.

Rapid synthesis of PEGylated ultrasmall gadolinium oxide nanoparticles for cell labeling and tracking with MRI.

Faucher L, Tremblay M, Lagueux J, Gossuin Y, Fortin MA.

ACS Appl Mater Interfaces. 2012 Sep 26;4(9):4506-15. Epub 2012 Aug 17.

PMID:
22834680
5.

An evaluation of gadolinium polyoxometalates as possible MRI contrast agent.

Feng J, Li X, Pei F, Sun G, Zhang X, Liu M.

Magn Reson Imaging. 2002 Jun;20(5):407-12.

PMID:
12206866
6.
7.

Gadolinium-chitosan nanoparticles as a novel contrast agent for potential use in clinical bowel-targeted MRI: a feasibility study in healthy rats.

Cheng JJ, Zhu J, Liu XS, He DN, Xu JR, Wu LM, Zhou J, Feng Q.

Acta Radiol. 2012 Oct 1;53(8):900-7. doi: 10.1258/ar.2012.110017. Epub 2012 Aug 22.

PMID:
22919051
8.

MRI of focal cerebral ischemia using (17)O-labeled water.

de Crespigny AJ, D'Arceuil HE, Engelhorn T, Moseley ME.

Magn Reson Med. 2000 Jun;43(6):876-83.

9.

[Comparison of MultiHance and Gadovist for cerebral MR perfusion imaging in healthy volunteers].

Essig M, Lodemann KP, LeHuu M, Schönberg SO, Hübener M, Van Kaick G.

Radiologe. 2002 Nov;42(11):909-15. German.

PMID:
12458444
10.

Comparison between GdDTPA and two gadolinium polyoxometalates as potential MRI contrast agents.

Feng J, Sun G, Pei F, Liu M.

J Inorg Biochem. 2002 Nov 25;92(3-4):193-9.

PMID:
12433428
11.

Using two chemical exchange saturation transfer magnetic resonance imaging contrast agents for molecular imaging studies.

Ali MM, Liu G, Shah T, Flask CA, Pagel MD.

Acc Chem Res. 2009 Jul 21;42(7):915-24. doi: 10.1021/ar8002738.

PMID:
19514717
12.

A new method for imaging perfusion and contrast extraction fraction: input functions derived from reference tissues.

Kovar DA, Lewis M, Karczmar GS.

J Magn Reson Imaging. 1998 Sep-Oct;8(5):1126-34.

PMID:
9786152
13.

Hemorrhage detection during focused-ultrasound induced blood-brain-barrier opening by using susceptibility-weighted magnetic resonance imaging.

Liu HL, Wai YY, Chen WS, Chen JC, Hsu PH, Wu XY, Huang WC, Yen TC, Wang JJ.

Ultrasound Med Biol. 2008 Apr;34(4):598-606. doi: 10.1016/j.ultrasmedbio.2008.01.011. Epub 2008 Mar 3.

PMID:
18313204
14.

Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging.

Liang J, Sammet S, Yang X, Jia G, Takayama Y, Knopp MV.

Invest Radiol. 2010 May;45(5):233-44. doi: 10.1097/RLI.0b013e3181d54507.

PMID:
20351653
15.

[Myocardial microcirculation in humans--new approaches using MRI].

Wacker CM, Bauer WR.

Herz. 2003 Mar;28(2):74-81. German.

PMID:
12669220
16.

New oil-in-water magnetic emulsion as contrast agent for in vivo magnetic resonance imaging (MRI).

Ahmed N, Jaafar-Maalej C, Eissa MM, Fessi H, Elaissari A.

J Biomed Nanotechnol. 2013 Sep;9(9):1579-85.

PMID:
23980505
17.

Detection of brain pathology by magnetic resonance imaging of iron oxide micro-particles.

Anthony DC, Sibson NR, McAteer MA, Davis B, Choudhury RP.

Methods Mol Biol. 2011;686:213-27. doi: 10.1007/978-1-60761-938-3_9.

PMID:
21082373
18.

Gd complexes of diethylenetriaminepentaacetic acid conjugates of low-molecular-weight chitosan oligosaccharide as a new liver-specific MRI contrast agent.

Huang Y, Cao B, Yang X, Zhang Q, Han X, Guo Z.

Magn Reson Imaging. 2013 May;31(4):604-9. doi: 10.1016/j.mri.2012.09.004. Epub 2012 Oct 25.

PMID:
23102519
19.

Neuroimaging: do we really need new contrast agents for MRI?

Roberts TP, Chuang N, Roberts HC.

Eur J Radiol. 2000 Jun;34(3):166-78. Review.

PMID:
10927159
20.

Molecular magnetic resonance imaging of myocardial perfusion with EP-3600, a collagen-specific contrast agent: initial feasibility study in a swine model.

Spuentrup E, Ruhl KM, Botnar RM, Wiethoff AJ, Buhl A, Jacques V, Greenfield MT, Krombach GA, Günther RW, Vangel MG, Caravan P.

Circulation. 2009 Apr 7;119(13):1768-75. doi: 10.1161/CIRCULATIONAHA.108.826388. Epub 2009 Mar 23.

Supplemental Content

Support Center